Literature DB >> 4047734

The dysplastic nevus.

D E Elder.   

Abstract

Dysplastic nevi are distinctive cutaneous nevomelanocytic lesions that can be recognized clinically and histologically. They were first described as markers of risk for melanoma in members of hereditary melanoma-prone kindreds. Subsequently, they have been discovered in a significant fraction of patients with sporadic melanoma, and in apparently normal members of the community. It is likely that they constitute markers of risk for melanoma in these populations as well, but that the risk is much less than in members of melanoma-prone kindreds. Beyond their role as risk markers, there is evidence that dysplastic nevi may act as precursors of some melanomas. Thus, their recognition offers an opportunity for analysis of pathogenetic mechanisms in cutaneous melanoma. Most dysplastic nevi, however, are completely stable over long periods of observation. Since up to 5% or even more of the population may bear one or more of these common lesions on their skin, it is important that the profession does not create an epidemic of cancer-phobia by over-emphasizing the significance of a dysplastic nevus. Patients with dysplastic nevi should adopt sensible patterns of skin care.

Entities:  

Mesh:

Year:  1985        PMID: 4047734     DOI: 10.3109/00313028509063770

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  6 in total

1.  DNA repair synthesis following irradiation with 254-nm and 312-nm ultraviolet light is not diminished in fibroblasts from patients with dysplastic nevus syndrome.

Authors:  H W Thielmann; O Popanda; L Edler; A Böing; E G Jung
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

2.  Telomerase activity in melanocytic lesions: A potential marker of tumor biology.

Authors:  P Rudolph; C Schubert; S Tamm; K Heidorn; A Hauschild; I Michalska; S Majewski; G Krupp; S Jablonska; R Parwaresch
Journal:  Am J Pathol       Date:  2000-04       Impact factor: 4.307

Review 3.  [The dysplastic nevus. Separate entity, melanoma precursor or diagnostic dilemma?].

Authors:  A Roesch; M Landthaler; T Vogt
Journal:  Hautarzt       Date:  2003-09       Impact factor: 0.751

Review 4.  Melanoma risk factors and atypical moles.

Authors:  M L Williams; R W Sagebiel
Journal:  West J Med       Date:  1994-04

5.  Diagnostic assessment of two novel proliferation-specific antigens in benign and malignant melanocytic lesions.

Authors:  P Rudolph; T Lappe; C Schubert; D Schmidt; R M Parwaresch; E Christophers
Journal:  Am J Pathol       Date:  1995-12       Impact factor: 4.307

Review 6.  Atypical mole syndrome and dysplastic nevi: identification of populations at risk for developing melanoma - review article.

Authors:  Juliana Hypólito Silva; B C de Sá; Alexandre Leon Ribeiro de Avila; Gilles Landman; João Pedreira Duprat Neto
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.